// App-Quantinova.ai

PO‐155 : Commutability – the importance of valid material for quality control in haemostasis

Researchers

Presenter

  • I Jennings

Principal Investigators

  • D Kitchen

  • L Brown

  • S Munroe-Peart

  • S Kitchen

  • T Woods

  • I Walker

Medical Centers

  • UK NEQAS (Blood Coagulation), UK NEQAS (Blood Coagulation), Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Activated partial thromboplastin time

Drug/Treatment

  • Heparin

  • rivaroxaban

  • Enoxaparin

  • Enoxaparin sodium

  • Pradax

  • apixaban

  • FVIIIFc

  • Heparin

  • Advate

  • FVIII

Outcome

  • N/A

Study Design

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved